These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17529996)

  • 61. Effect of Granulocyte-Macrophage Colony-Stimulating Factor on Prevention and Treatment of Invasive Fungal Disease in Recipients of Allogeneic Stem-Cell Transplantation: A Prospective Multicenter Randomized Phase IV Trial.
    Wan L; Zhang Y; Lai Y; Jiang M; Song Y; Zhou J; Zhang Z; Duan X; Fu Y; Liao L; Wang C
    J Clin Oncol; 2015 Dec; 33(34):3999-4006. PubMed ID: 26392095
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years.
    Hovi L; Saarinen-Pihkala UM; Vettenranta K; Saxen H
    Bone Marrow Transplant; 2000 Nov; 26(9):999-1004. PubMed ID: 11100280
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Caspofungin as salvage monotherapy for invasive aspergillosis in patients with haematological malignancies or following allogeneic stem cell transplantation: efficacy and concomitant cyclosporin A.
    Morrissey CO; Slavin MA; O'Reilly MA; Daffy JR; Seymour JF; Schwarer AP; Szer J
    Mycoses; 2007; 50 Suppl 1():24-37. PubMed ID: 17394607
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections.
    Nivoix Y; Zamfir A; Lutun P; Kara F; Remy V; Lioure B; Rigolot JC; Entz-Werlé N; Letscher-Bru V; Waller J; Levêque D; Koffel JC; Beretz L; Herbrecht R
    J Infect; 2006 Jan; 52(1):67-74. PubMed ID: 16368463
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Experiences with the use of caspofungin in paediatric patients.
    Lehrnbecher T; Groll AH
    Mycoses; 2008; 51 Suppl 1():58-64. PubMed ID: 18471162
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.
    Pavie J; Lacroix C; Hermoso DG; Robin M; Ferry C; Bergeron A; Feuilhade M; Dromer F; Gluckman E; Molina JM; Ribaud P
    J Clin Microbiol; 2005 Sep; 43(9):4902-4. PubMed ID: 16145172
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Initial fluconazole prophylaxis may not be required in adults with acute leukemia or myelodysplastic/myeloproliferative disorders after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation.
    Brissot E; Cahu X; Guillaume T; Delaunay J; Ayari S; Peterlin P; Le Bourgeois A; Harousseau JL; Milpied N; Bene MC; Moreau P; Mohty M; Chevallier P
    Ann Hematol; 2015 Apr; 94(4):663-9. PubMed ID: 25409914
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical efficacy and tolerability of caspofungin in a renal transplant patient with Aspergillus flavus lung infection: case report.
    Pasticci MB; Barchiesi F; Fallani S; Palladino N; Lapalorcia LM; Gubbiotti M; Cozzari M; Novelli A; Baldelli F
    J Chemother; 2006 Oct; 18(5):549-53. PubMed ID: 17127234
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases.
    Miyakoshi S; Kusumi E; Matsumura T; Hori A; Murashige N; Hamaki T; Yuji K; Uchida N; Masuoka K; Wake A; Kanda Y; Kami M; Tanaka Y; Taniguchi S
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):771-7. PubMed ID: 17580255
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Risk Factors for Invasive Fungal Infection in Children and Adolescents With Hematologic and Malignant Diseases: A 10-year Analysis in a Single Institute in Japan.
    Kobayashi R; Hori D; Sano H; Suzuki D; Kishimoto K; Kobayashi K
    Pediatr Infect Dis J; 2018 Dec; 37(12):1282-1285. PubMed ID: 30408007
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
    Maertens J
    Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Successful treatment of cutaneous alternariosis with caspofungin in a renal transplant recipient.
    Seyfarth F; Goetze S; Gräser Y; Kaatz M; Ott U; Rüster C; Edel B; Elsner P; Hipler UC
    Mycoses; 2012 Sep; 55(5):457-62. PubMed ID: 22329778
    [No Abstract]   [Full Text] [Related]  

  • 73. New Perspectives on Primary Prophylaxis of Invasive Fungal Infection in Children Undergoing Hematopoietic Stem Cell Transplantation: A 10-Year Retrospective Cohort Study.
    Ricard N; Zebali L; Renard C; Goutagny MP; Benezech S; Bertrand Y; Philippe M; Domenech C
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046769
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Outcomes of Hematopoietic Cell Transplantation in Patients with Mixed Response to Pretransplantation Treatment of Confirmed or Suspected Invasive Fungal Infection.
    Ford ES; Duke ER; Cheng GS; Yoke LM; Liu C; Hill JA; Pergam SA; Pipavath SNJ; Walter RB; Mielcarek M; Schiffer JT; Boeckh M
    Transplant Cell Ther; 2021 Aug; 27(8):684.e1-684.e9. PubMed ID: 33964516
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Invasive pulmonary fungal infection accompanied by severe hemoptysis in patients with hematologic diseases: a report of nine cases.
    Qiu L; He J; Ye X; Xie W; Shi J; Zheng W; Sun J; Zhu X; Cai Z; Huang H; Lin M
    Int J Hematol; 2009 Jul; 90(1):108-112. PubMed ID: 19484336
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage.
    Gedik H; Simşek F; Yıldırmak T; Kantürk A; Arıca D; Aydın D; Demirel N; Yokuş O
    Ther Clin Risk Manag; 2014; 10():305-12. PubMed ID: 24855365
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multicentre surveillance study on feasibility, safety and efficacy of antifungal combination therapy for proven or probable invasive fungal diseases in haematological patients: the SEIFEM real-life combo study.
    Candoni A; Caira M; Cesaro S; Busca A; Giacchino M; Fanci R; Delia M; Nosari A; Bonini A; Cattaneo C; Melillo L; Caramatti C; Milone G; Scime' R; Picardi M; Fanin R; Pagano L;
    Mycoses; 2014 Jun; 57(6):342-50. PubMed ID: 24373120
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis.
    Kohno S; Izumikawa K; Yoshida M; Takesue Y; Oka S; Kamei K; Miyazaki Y; Yoshinari T; Kartsonis NA; Niki Y
    Eur J Clin Microbiol Infect Dis; 2013 Mar; 32(3):387-97. PubMed ID: 23052987
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study).
    Jarque I; Tormo M; Bello JL; Rovira M; Batlle M; Julià A; Tabares S; Rivas C; Fernández-Sevilla A; García-Boyero R; Debén G; González-Campos J; Capote FJ; Sanz MA;
    Med Mycol; 2013 Feb; 51(2):150-4. PubMed ID: 22712457
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A prospective, randomized study of empirical antifungal therapy for the treatment of chemotherapy-induced febrile neutropenia in children.
    Caselli D; Cesaro S; Ziino O; Ragusa P; Pontillo A; Pegoraro A; Santoro N; Zanazzo G; Poggi V; Giacchino M; Livadiotti S; Melchionda F; Chiodi M; Aricò M
    Br J Haematol; 2012 Jul; 158(2):249-255. PubMed ID: 22571507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.